Aktiia's technology for measuring blood pressure with a wearable and a mobile phone is being tested in a clinical trial at the CHUV (Lausanne University Hospital). The video explains the background.
Principal
Swiss Venture Capital Report
The new Swiss Venture Capital Report provides a review of the whole of 2023. In addition to investments, the report will once again include the results of a survey of Swiss investors, an overview of venture capital fundraising and a list of exits. You can download the Report in our asset section.